信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·益佰制药2022年预计亏损3.67亿-4.4亿同比由盈转亏主要产品收入下滑2023-1-21 1:55:04
·股票行情快报：*ST吉药（300108）1月20日主力资金净买入84.44万元2023-1-21 1:42:26
·股票行情快报：佛慈制药（002644）1月20日主力资金净买入321.15万元2023-1-21 0:22:43
·艾迪药业2022年预计亏损1亿-1.4亿同比亏损增加管理费用增加2023-1-20 22:52:03
·股票行情快报：威尔药业（603351）1月20日主力资金净卖出24.47万元2023-1-20 21:57:31
·辉瑞新冠口服药降温：平台降价1000多元2023-1-20 21:27:15
·维康药业2022年预计净利8030万-1亿同比增长-17%至4%医药工业产品销售收入下降2023-1-20 21:23:53
·重回900亿！四季度再度加仓药明康德、恒瑞医药葛兰坦言：短期波动难避免2023-1-20 21:18:15
·香雪制药2022年预计亏损4.53亿-6.29亿同比亏损减少成药产品销售不达预期2023-1-20 20:47:15
·康芝药业2022年预计亏损1.72亿-2.45亿同比由盈转亏个别产品代理期限到期2023-1-20 20:25:57
·真实生物联合复星医药组织多家生产企业联合扩产新冠口服药阿兹夫定2023-1-20 19:25:22
·复星医药：复必泰二价疫苗于中国澳门获批为常规进口疫苗2023-1-20 17:24:27
·复星医药：复必泰二价疫苗于中国澳门获批为常规进口疫苗2023-1-20 17:15:45
·退烧药便宜卖的“良心企业”东北制药因垄断被罚款1.33亿2023-1-20 17:08:06
·康弘药业2022年预盈近9亿同比翻倍手握258项发明专利加码创新药布局2023-1-20 13:42:31
·以岭药业：益肾养心安神片、解郁除烦胶囊等系列专利中药进入最新版国家医保目录2023-1-20 12:09:57
·东北制药业绩预增183%-304%半数研发投入资本化或在粉饰业绩2023-1-20 9:10:09
·坦然接受体系缺陷！张坤上季度规模业绩齐回升增配茅台药明2023-1-20 9:01:35
·东北制药2022年预计净利2.8亿-4亿同比增长183%-304%销售收入增长2023-1-20 2:32:47
·雪球资管展望新年投资机遇，医药、新能源等领域被看好2023-1-20 0:29:42

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]